Skip to content
The Barcelona Debates on the Human Microbiome 2025 Logo The Barcelona Debates on the Human Microbiome 2025 Logo The Barcelona Debates on the Human Microbiome 2025 Logo
  • Home
  • Faculty
    • Coordinators
    • Scientific Committee
  • Program
  • Abstracts
  • Registration
  • Support
  • Practical Info
  • Organizer
    • IrsiCaixa
    • Technical Secretariat
  • Previous Editions
    • 2019
      • Organizer 2019
      • Practical Info
      • Sponsors 2019
      • Collaborators
      • Program
      • Speakers and Chairs
      • Scientific Committee 2019
      • Coordinators 2019
      • Material Downloads
    • 2020
      • Home 2020
      • Faculty 2020
        • Organizer 2020
        • Coordinators 2020
        • Speakers 2020
      • Program 2020
      • Support 2020
      • Practical Info 2020
    • 2022
      • Home 2022
      • Faculty 2022
        • Organizer 2022
        • Coordinators 2022
        • Scientific Committee 2022
        • Speakers 2022
      • Program 2022
      • Support 2022
      • Practical Info 2022
    • 2023
      • Home 2023
      • Faculty 2023
        • Organizer 2023
        • Coordinators 2023
        • Scientific Committee 2023
        • Speakers 2023
      • Program 2023
      • Abstracts 2023
      • Registration 2023
      • Support 2023
      • Practical Info 2023
    • 2024
      • Home 2024
      • Faculty 2024
        • Coordinators 2024
        • Scientific Committee 2024
      • Program 2024
      • Abstracts 2024
      • Posters 2024
      • Registration 2024
      • Support 2024
      • Practical Info 2024
      • Organizer 2024
        • IrsiCaixa 2024
        • Technical Secretariat 2024

Program 2022

  1. Home
  2. Program 2022
Program 2022Marc Camprecios2023-01-24T15:15:31+00:00
Download Program in PDF

Thursday 30th June 2022

8.30 REGISTRATION
Front Desk
9.15 WELCOME

Àngel Font, Corporate Director of Research and Health of “la Caixa” Foundation, Spain

Roger Paredes, IrsiCaixa AIDS Research Institute. Hospital Universitari Germans Trias i Pujol. Fight Infections Foundation, Spain

Francisco Guarner, Vall d’Hebron Research Institute (VHIR), Spain

9.30 to 11.30

Covid-19

Chair: Jose Maria Miró, Hospital Clínic de Barcelona, Spain

9.30 Lung microbiome in COVID-19
Frederic Bushman, University of Pennsylvania, USA
10.00 Novel Insights into Gut Microbiome in Acute and Post-acute COVID-19 Syndrome?
Siew C Ng, Chinese University of Hong Kong, China
10.30 Overall discussion
11.00 Coffee break

11.30 to 14.00

Cancer

Chair: Xavier Aldeguer, Ministry of Research and Universities of the Government of Catalonia, Spain

11.30 The gut microbiota in cancer therapy
Paolo Nuciforo, Vall d’Hebron Institute of Oncology, Spain
12.00 Vaginal microbiome and cervical cancer
Adam Burgener, Center for Global Health and Diseases at Case Western Reserve University, USA
12.30 Overall discussion
13.00 Lunch

14.00 to 16.00

Strain-resolved metagenomics and microbiome transmission

Chair: Marc Noguera, IrsiCaixa AIDS Research Institute. Hospital Universitari Germans Trias i Pujol, Spain

14.00 Strain-level metagenomics to uncover the unknowns in the microbiome
Nicola Segata, Computational Metagenomics, Department CIBIO, Italy
14.30 Person-to-person transmission of the human microbiome
Mireia Vallès-Colomer, University of Trento, Italy
15.00 Overall discussion
15.30 Coffee break

16.00 to 18.00

Metabolic disorders

Chair: Karine Clement, Sorbonne Université, INSERM, France

16.00 Involvement of the microbiome in body weight gain after smoking cessation
Hagit Shapiro, Weizmann Institute of Science, Israel
16.30 Gut microbiome dysbiosis precedes type 2 diabetes and ischaemic heart disease
Oluf Pedersen, University of Copenhagen, Denmark
17.00 Overall discussion
17.30 Welcome reception

Friday 1st July 2022

9.30 to 11.30

Dynamics of the Microbiome

Chair: Roger Paredes, IrsiCaixa AIDS Research Institute. Hospital Universitari Germans Trias i Pujol. Fight Infections Foundation, Spain

9.30 Vertical transmission: neonatal acquisition of the microbiome
Maria Carmen Collado, Instituto de Agroquímica y Tecnología de Alimentos (IATA), Spain
10.00 Horizontal transmission of gut microbes between adult individuals
Stanislav Dusko Ehrlich, Institut National de la Recherche Agronomique (INRA), France
10.30 Overall discussion
11.00 Coffee break

11.30 to 13.30

Inflammatory Bowel Diseases

Chairs: Chaysavanh Manichanh, VHIR, Spain & Natalia Borruel, VHIR, Spain

11.30 Autologous fecal microbiota transfer in acute myeloid leukemia patients
Joël Doré, Institut National de la Recherche Agronomique, France
12.00 Trials testing FMT in IBD
Harry Sokol, Sorbonne Université, APHP, INSERM, INRA, France
12.30 Overall discussion
13.00 Meeting closure

Francisco Guarner, VHIR, Spain

Thanks to the support of

La Caixa
© Copyright    |   ScienHub   |   PRIVACY POLICY   |   TERMS AND CONDITIONS   |   ALL RIGHTS RESERVED 

The logistics of the meeting as well as this website are managed by ScienHub, an entity of Fundació Lluita contra les Infeccions (lluita.org). For more information contact us at or visit scienhub.org

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Page load link
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage {vendor_count} vendors Read more about these purposes
View preferences
{title} {title} {title}
0
    0
    Your Cart
    Your cart is empty
    Go to Top